Soligenix, Inc. Files 8-K: Material Agreement & Financials

TL;DR

SOLIGENIX (SNGX) filed an 8-K on 4/17 reporting a material agreement and financials - details pending.

AI Summary

On April 17, 2024, Soligenix, Inc. entered into a Material Definitive Agreement. The company also reported other events and filed financial statements and exhibits as part of this 8-K filing. Specific details of the agreement and financial information were not provided in the initial filing.

Why It Matters

This filing indicates a significant new agreement for Soligenix, Inc., which could impact its future operations and financial performance. Investors will be looking for details on the nature and terms of this agreement.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which could be positive or negative depending on the specifics, and the company has also filed financial statements, suggesting ongoing operational activity and reporting requirements.

Key Players & Entities

• Soligenix, Inc. (company) — Filer of the 8-K report
• April 17, 2024 (date) — Date of the earliest event reported
• 001-14778 (other) — Commission File Number for Soligenix, Inc.
• 29 Emmons Drive, Suite B-10 Princeton, NJ 08540 (location) — Business and mailing address of Soligenix, Inc.

FAQ

Key Financial Figures

• $0.40 — arrants was sold at a per unit price of $0.40. Each unit comprised of pre-funded warr
• $0 — arrants was sold at a per unit price of $0.399, which represents the same per unit
• $0.001 — esents the same per unit price less the $0.001 per share exercise price of the pre-fun
• $4.75 million — eds from the Offering are approximately $4.75 million before deducting placement agent fees a
• $75,000 — tion with the Offering in the amount of $75,000, and non-accountable expenses equal to
• $15,000 — , and non-accountable expenses equal to $15,000. The shares of common stock, the pre-f

Filing Documents

• sngx-20240417x8k.htm (8-K) — 44KB
• sngx-20240417xex4d1.htm (EX-4.1) — 127KB
• sngx-20240417xex4d2.htm (EX-4.2) — 139KB
• sngx-20240417xex10d1.htm (EX-10.1) — 81KB
• sngx-20240417xex10d2.htm (EX-10.2) — 435KB
• sngx-20240417xex99d1.htm (EX-99.1) — 21KB
• sngx-20240417xex99d1001.jpg (GRAPHIC) — 14KB
• 0001558370-24-005411.txt ( ) — 1153KB
• sngx-20240417.xsd (EX-101.SCH) — 4KB
• sngx-20240417_def.xml (EX-101.DEF) — 3KB
• sngx-20240417_lab.xml (EX-101.LAB) — 12KB
• sngx-20240417_pre.xml (EX-101.PRE) — 10KB
• sngx-20240417x8k_htm.xml (XML) — 5KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement On April 17, 2024, Soligenix, Inc., a Delaware corporation (the "Company") entered into a Securities Purchase Agreement with certain investors (the "Investors"), pursuant to which the Company agreed to issue and sell to the Investors in a public offering (the "Offering") (i) 3,275,000 shares of the Company's common stock, (ii) pre-funded warrants to purchase 8,600,000 shares of the Company's common stock and (iii) common warrants to purchase 11,875,000 shares of the Company's common stock. The shares of common stock, or pre-funded warrants in lieu thereof, and the common warrants, were sold in units, with each unit consisting of one share of common stock or one pre-funded warrant in lieu thereof and one common warrant. Each unit comprised of common stock and common warrants was sold at a per unit price of $0.40. Each unit comprised of pre-funded warrants and common warrants was sold at a per unit price of $0.399, which represents the same per unit price less the $0.001 per share exercise price of the pre-funded warrants. The common warrants are exercisable at a price of $0.40 per share and have a five-year term. The Securities Purchase Agreement contains customary conditions to closing, representations and warranties of the Company, and termination rights of the parties, as well as certain indemnification obligations of the Company and ongoing covenants of the Company. Pursuant to the Securities Purchase Agreement, the Company has also agreed not to offer, issue, sell, contract to sell, or grant any option for the sale of or otherwise dispose of the Company's securities for a period of 90 days following the closing of the Offering. The Company has further agreed not to enter into any variable rate transaction for a period of one year following the closing of the Offering; provided, however, that this restriction does not apply with respect to an at-the-market offering from the 90 th day following the closing da

01. Other Events

Item 8.01. Other Events. On April 18, 2024, the Company issued a press release announcing the Offering. A copy of this press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 4.1 Form of Pre-Funded Warrant. 4.2 Form of Common Warrant. 10.1 Placement Agency Agreement dated April 17, 2024. 10.2 Securities Purchase Agreement dated April 17, 2024. 99.1 Press Release dated April 18, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Soligenix, Inc. April 22, 2024 By: /s/ Christopher J. Schaber Christopher J. Schaber, Ph.D. President and Chief Executive Officer (Principal Executive Officer) 4

View Full Filing

View this 8-K filing on SEC EDGAR